Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
606.00    -7.00 (-1.14%)
Bid:
606.00
Ask:
608.00
Spread: 2.00 (0.33%)
Market Cap: £672.51m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Merger Update

14 Feb 2013 10:22

RNS Number : 8895X
Barr(A.G.) PLC
14 February 2013
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

For Immediate Release

14 February 2013

A.G. BARR p.l.c. ("A.G. Barr") and Britvic plc ("Britvic")

All-share merger update: decision to seek Competition Commission clearance

The Boards of A.G. Barr and Britvic refer to their joint announcement noting the decision by the Office of Fair Trading (the "OFT") to refer the proposed merger of A.G. Barr and Britvic (the "Merger") to the Competition Commission due to concerns that the Merger could reduce competition between certain brands of A.G. Barr and Britvic.

 

A.G. Barr and Britvic believe that the merger will not result in a substantial lessening of competition and that they will be able to demonstrate this to the Competition Commission. The Boards of A.G. Barr and Britvic therefore intend to work together with the Competition Commission during its investigation with a view to seeking clearance of the proposed merger. The Competition Commission's investigation is expected to take approximately six months. If clearance is received from the Competition Commission on terms satisfactory to both A.G. Barr and Britvic, the Boards of A.G. Barr and Britvic will each reconsider, at that time, the terms of a possible merger between A.G. Barr and Britvic. There can be no certainty or assurance that, following such clearance, any such merger would be forthcoming or that any offer will be made by either A.G. Barr or Britvic.

 

A.G. Barr and Britvic consider there to be compelling rationale for clearance. The view of the two Boards on the benefits of the transaction is unchanged and they continue to believe that it is in the interests of the two shareholder groups. A.G. Barr and Britvic will continue to work closely with the authorities to expedite clearance.

 

Capitalised terms used but not defined in this announcement have the same meanings as set out in the Scheme Document dated 5 December 2012.

Enquiries

A.G. BARR p.l.c.

Roger White

Alex Short +44 (0) 1236 852 400

Rothschild (financial adviser to A.G. Barr)

Akeel Sachak

Stuart Vincent

Jessica Dale +44 (0) 207 280 5000

Investec Bank plc (broker to A.G. Barr)

Keith Anderson

David Anderson

Henry Reast +44 (0) 207 597 5970

College Hill (PR adviser to A.G. Barr)

Justine Warren

Matthew Smallwood +44 (0) 207 457 2020

Britvic plc

Gerald Corbett

John Gibney

Rupen Shah

Steve Nightingale +44 (0) 1442 284330

Citigroup Global Markets Limited

(joint financial adviser and joint broker to Britvic)

David Wormsley

Jan Skarbek

Andrew Seaton +44 (0) 207 986 4000

Nomura International plc

(joint financial adviser and joint broker to Britvic)

Nicholas Marren

Ed Matthews +44 (0) 207 521 2000

Brunswick (PR adviser to Britvic)

Mike Smith

Nick Cosgrove +44 (0) 207 404 5959

 

Rothschild, which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for A.G. Barr and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than A.G. Barr for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Investec Bank plc, which is authorised and regulated in the United Kingdom by the FSA, is acting as corporate broker to A.G. Barr and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than A.G. Barr for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Citigroup Global Markets Limited, which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for Britvic and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than Britvic for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Nomura International plc, which conducts its UK investment banking business as Nomura, is authorised and regulated in the United Kingdom by the FSA and is acting as joint broker and joint financial adviser to Britvic and for no-one else in connection with the matters set out in this announcement. Nomura will not be responsible to anyone other than Britvic for providing the protection afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Publication on website

A copy of this announcement will be made available, free of charge, subject to certain restrictions relating to persons resident in restricted jurisdictions, on Britvic's and A.G. Barr's websites at http://ir.britvic.comand www.agbarr.co.ukrespectively by no later than noon (London time) on the day following the date of this announcement. For the avoidance of doubt, the contents of those websites are not incorporated into and do not form part of this announcement.

You may request a hard copy of this announcement by contacting the Company Secretary of Britvic at company.secretariat@britvic.co.uk (or on +44(0)1442 284411) or by writing to Britvic plc, Breakspear Park, Breakspear Way, Hemel Hempstead, HP2 4TZ, or by contacting the Company Secretary of A.G. Barr at companysecretarialdepartment@agbarr.co.uk (or on +44(0)1236 852400) or by writing to A.G. BARR p.l.c., Westfield House, 4 Mollins Road, Cumbernauld, G68 9HD. You may also request that all future documents, announcements and information to be sent to you in relation to the Merger should be in hard copy form.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MERZMGMZGDMGFZM
Date   Source Headline
8th Nov 202310:45 amRNSDirector/PDMR Shareholding
3rd Nov 20233:44 pmRNSDirector/PDMR Shareholding
30th Oct 20233:10 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSAcquisition of tropical drinks brand Rio
10th Oct 20238:21 amRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSInterim Results
11th Sep 20239:08 amRNSDirector/PDMR Shareholding
8th Aug 20232:07 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSBoard succession announcement
1st Aug 20237:00 amRNSTrading update for the 26 weeks ended 30 July 2023
10th Jul 202312:42 pmRNSDirector/PDMR Shareholding
14th Jun 20239:40 amRNSDirector/PDMR Shareholding
13th Jun 20239:24 amRNSDirector/PDMR Shareholding - Replacement
13th Jun 20238:59 amRNSDirector/PDMR Shareholding
13th Jun 20238:55 amRNSDirector/PDMR Shareholding
12th Jun 20233:59 pmRNSDirector/PDMR Shareholding
8th Jun 20231:02 pmRNSDirector/PDMR Shareholding
26th May 20231:57 pmRNSDirectorate Change
26th May 20231:55 pmRNSResult of AGM
10th May 20239:25 amRNSDirector/PDMR Shareholding
4th May 20239:22 amRNSDirector Declaration
25th Apr 20239:14 amRNSAnnual Financial Report / Notice of AGM
12th Apr 20233:31 pmRNSDirector/PDMR Shareholding
12th Apr 202311:23 amRNSDirector/PDMR Shareholding
11th Apr 202310:07 amRNSDirector/PDMR Shareholding
30th Mar 202310:24 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSBoard succession update
28th Mar 20237:00 amRNSFinal results for the year ended 29 January 2023
8th Mar 202310:57 amRNSDirector/PDMR Shareholding
8th Feb 202311:09 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTrading Update
27th Jan 20232:39 pmRNSNotice of Trading Update
10th Jan 20232:01 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSAcquisition of MOMA minority shareholding
14th Dec 20226:00 pmRNSContourGlobal
8th Dec 202212:56 pmRNSDirector/PDMR Shareholding
5th Dec 20227:00 amRNSAcquisition of Boost Drinks Holdings Limited
8th Nov 202210:41 amRNSDirector/PDMR Shareholding
1st Nov 20222:38 pmRNSDirector/PDMR Shareholding
1st Nov 20222:34 pmRNSDirector/PDMR Shareholding
1st Nov 20222:30 pmRNSDirector/PDMR Shareholding
25th Oct 20229:34 amRNSDirectorship
10th Oct 20221:44 pmRNSDirector/PDMR Shareholding
27th Sep 20227:05 amRNSUpdate statement on 2022 AGM Voting Results
27th Sep 20227:00 amRNSInterim Results
12th Sep 20223:18 pmRNSHolding(s) in Company
8th Sep 20222:08 pmRNSDirector/PDMR Shareholding
31st Aug 202210:29 amRNSNotice of Interim Results Date
8th Aug 20221:05 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.